Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias W Beckmann

Showing results (671-680 of 799) with videos related to

Pageof 80
Sort By:
European Journal of Cancer (Oxford, England : 1990)|August 7, 2022
Incorporating progesterone receptor expression into the PREDICT breast prognostic modelIsabelle Grootes, Renske Keeman, Fiona M Blows, et al.
Medrxiv : the Preprint Server for Health Sciences|November 21, 2023
Concurrent RB1 loss and <i>BRCA</i>-deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinomaFlurina A M Saner, Kazuaki Takahashi, Timothy Budden, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 11, 2015
Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer riskXingyi Guo, Jirong Long, Chenjie Zeng, et al.
Scientific Reports|September 8, 2016
Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs)Hatef Darabi, Jonathan Beesley, Arnaud Droit, et al.
Human Molecular Genetics|July 13, 2016
An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expressionAsaf Wyszynski, Chi-Chen Hong, Kristin Lam, et al.
Genome Medicine|May 18, 2022
Breast cancer risks associated with missense variants in breast cancer susceptibility genesLeila Dorling, Sara Carvalho, Jamie Allen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2022
Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse OutcomesNicola S Meagher, Kylie L Gorringe, Matthew Wakefield, et al.
Plos Medicine|August 24, 2016
Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European DescentYan Guo, Shaneda Warren Andersen, Xiao-Ou Shu, et al.
Plos One|August 25, 2016
Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility LocusHisani N Horne, Charles C Chung, Han Zhang, et al.
Human Genetics|April 15, 2016
Assessing the genetic architecture of epithelial ovarian cancer histological subtypesGabriel Cuellar-Partida, Yi Lu, Suzanne C Dixon, et al.
Pageof 80

Showing results (671-680 of 799) with videos related to

Sort By:
Pageof 80
European Journal of Cancer (Oxford, England : 1990)|August 7, 2022
Incorporating progesterone receptor expression into the PREDICT breast prognostic modelIsabelle Grootes, Renske Keeman, Fiona M Blows, et al.
Medrxiv : the Preprint Server for Health Sciences|November 21, 2023
Concurrent RB1 loss and <i>BRCA</i>-deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinomaFlurina A M Saner, Kazuaki Takahashi, Timothy Budden, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 11, 2015
Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer riskXingyi Guo, Jirong Long, Chenjie Zeng, et al.
Scientific Reports|September 8, 2016
Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs)Hatef Darabi, Jonathan Beesley, Arnaud Droit, et al.
Human Molecular Genetics|July 13, 2016
An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expressionAsaf Wyszynski, Chi-Chen Hong, Kristin Lam, et al.
Genome Medicine|May 18, 2022
Breast cancer risks associated with missense variants in breast cancer susceptibility genesLeila Dorling, Sara Carvalho, Jamie Allen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2022
Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse OutcomesNicola S Meagher, Kylie L Gorringe, Matthew Wakefield, et al.
Plos Medicine|August 24, 2016
Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European DescentYan Guo, Shaneda Warren Andersen, Xiao-Ou Shu, et al.
Plos One|August 25, 2016
Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility LocusHisani N Horne, Charles C Chung, Han Zhang, et al.
Human Genetics|April 15, 2016
Assessing the genetic architecture of epithelial ovarian cancer histological subtypesGabriel Cuellar-Partida, Yi Lu, Suzanne C Dixon, et al.
Pageof 80